In this issue:
- Paclitaxel-coated devices: US FDA removes red flag after review finds data do not support mortality risk
- “A hugely exciting time”: Experts focus in on artificial intelligence in the vascular field
- In profile: Jürgen Falkensammer (Vienna, Austria)
- Journal highlight: Computer model indicates optimal shielding can reduce operator radiation doses close to “background” levels
- Advertorial: “Valuable” 10-year data on the horizon for Gore‘s GREAT registry
